Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49. State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705. State of the Art and Science Oct 2020 Using OCAP and IQ as Frameworks to Address a History of Trauma in Indigenous Health Research Angela Mashford-Pringle, PhD and Kira Pavagadhi, MPH Researchers and scholars should co-develop research with Indigenous peoples to ensure respect for culture, language, and ways of knowing. AMA J Ethics. 2020;22(10):E868-873. doi: 10.1001/amajethics.2020.868. State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. State of the Art and Science Aug 2022 How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients Antonio D. Garcia and Ximena Lopez, MD Transgender people commonly experience discrimination from clinicians, which directly contributes to worse mental and physical health outcomes. AMA J Ethics. 2022;24(8):E753-761. doi: 10.1001/amajethics.2022.753. State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762. State of the Art and Science Sep 2017 Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers Amy B. Cadwallader, PhD Probation programs that use a frequent, random urine drug testing (UDT) coupled with swift consequences for violations reduce drug use and recidivism. AMA J Ethics. 2017;19(9):931-938. doi: 10.1001/journalofethics.2017.19.9.stas2-1709. State of the Art and Science Sep 2005 Approach to the Patient with Alcoholic Liver Disease Howard J. Worman, MD Virtual Mentor. 2005;7(9):600-603. doi: 10.1001/virtualmentor.2005.7.9.cprl1-0509. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
State of the Art and Science Jan 2021 “Prevention” and Human Gene Editing Governance Eric T. Juengst, PhD The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention. AMA J Ethics. 2021;23(1):E49-54. doi: 10.1001/amajethics.2021.49.
State of the Art and Science Sep 2021 What Should Cardiac Patients Know About Device Cybersecurity Prior to Implantation? Emily P. Zeitler, MD, MHS and Daniel B. Kramer, MD, MPH Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key. AMA J Ethics. 2021;23(9):E705-711. doi: 10.1001/amajethics.2021.705.
State of the Art and Science Oct 2020 Using OCAP and IQ as Frameworks to Address a History of Trauma in Indigenous Health Research Angela Mashford-Pringle, PhD and Kira Pavagadhi, MPH Researchers and scholars should co-develop research with Indigenous peoples to ensure respect for culture, language, and ways of knowing. AMA J Ethics. 2020;22(10):E868-873. doi: 10.1001/amajethics.2020.868.
State of the Art and Science Nov 2020 How Might Artificial Intelligence Applications Impact Risk Management? John Banja, PhD AI models might advance human welfare in unprecedented ways, but progress will not occur without substantial risks that will have to be managed. AMA J Ethics. 2020;22(11):E945-951. doi: 10.1001/amajethics.2020.945.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
State of the Art and Science Aug 2022 How Cisgender Clinicians Can Help Prevent Harm During Encounters With Transgender Patients Antonio D. Garcia and Ximena Lopez, MD Transgender people commonly experience discrimination from clinicians, which directly contributes to worse mental and physical health outcomes. AMA J Ethics. 2022;24(8):E753-761. doi: 10.1001/amajethics.2022.753.
State of the Art and Science Aug 2022 What Should Clinicians and Patients Know About the Clinical Gaze, Disability, and Iatrogenic Harm When Making Decisions? Chloë G. K. Atkins, PhD and Sunit Das, MD, PhD Avoiding harm requires that clinicians not overly rely on assumptions about “normal” embodiment. AMA J Ethics. 2022;24(8):E762-767. doi: 10.1001/amajethics.2022.762.
State of the Art and Science Sep 2017 Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers Amy B. Cadwallader, PhD Probation programs that use a frequent, random urine drug testing (UDT) coupled with swift consequences for violations reduce drug use and recidivism. AMA J Ethics. 2017;19(9):931-938. doi: 10.1001/journalofethics.2017.19.9.stas2-1709.
State of the Art and Science Sep 2005 Approach to the Patient with Alcoholic Liver Disease Howard J. Worman, MD Virtual Mentor. 2005;7(9):600-603. doi: 10.1001/virtualmentor.2005.7.9.cprl1-0509.